Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer

by Maria Gaibar, Laura Beltrán, Alicia Romero-Lorca, Ana Fernández-Santander, Apolonia Novillo
Published 2020-01-01

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.

by Alicia Romero-Lorca, Apolonia Novillo, María Gaibar, Fernando Bandrés, Ana Fernández-Santander
Published 2015-01-01

Genetic Variants of <i>ANGPT1</i>, <i>CD39</i>, <i>FGF2</i> and <i>MMP9</i> Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer

by María Gaibar, Miguel Galán, Alicia Romero-Lorca, Beatriz Antón, Diego Malón, Amalia Moreno, Ana Fernández-Santander, Apolonia Novillo
Published 2021-01-01

Relationship between genotypes Sult1a2 and Cyp2d6 and tamoxifen metabolism in breast cancer patients.

by Ana Fernández-Santander, María Gaibar, Apolonia Novillo, Alicia Romero-Lorca, Margarita Rubio, Luis Miguel Chicharro, Armando Tejerina, Fernando Bandrés
Published 2013-01-01

Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer

by Apolonia Novillo, Ana Fernández-Santander, Maria Gaibar, Miguel Galán, Alicia Romero-Lorca, Fadoua El Abdellaoui-Soussi, Pablo Gómez-del Arco
Published 2021-04-01